StockData

Addex Therapeutics vs Kiora Pharmaceuticals

ADXN and KPRX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ADXN and KPRX compare

Kiora Pharmaceuticals scores higher on the StockData Score (7 against 0 for Addex Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricADXNKPRX
Size and price
Market cap–$4.3M
Share price$3.83$0.982
Change, 1 year−55.5%−55.3%
Change, 5 years−97.3%−99.8%
Beta (5Y)1.841.59
Employees33,500
StockData Score
Total score07 (better)
Valuation score01 (better)
Growth score00
Performance score01 (better)
Health score05 (better)
Dividend score00
Valuation
P/B–0.3×
FCF yield–−198%
Growth
Revenue growth (TTM)−92.6%–
Revenue growth, 5Y average−61.6%–
EPS growth (TTM)−186%–
Profitability
Operating margin−9391%–
FCF margin−7244%–
Return on equity–−56.4%
Return on invested capital–−1374%
Financial health
Debt / equity–0.00
Interest coverage−181.0×–
Current ratio0.768.97 (better)
Altman Z-score–−9.80
Piotroski F-score–3
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions0.00%25.0%
Held by insiders15.5%3.0%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.